TEG® hemostasis management systems from Haemonetics deliver fast, accurate information where and when you need it, so you can respond with confidence and optimize patient care.
The TEG 6s is the smallest viscoelastic analyzer system on the market and rapidly provides comprehensive identification of an individual’s hemostasis condition which allows clinicians to confidently drive treatment and monitoring decisions.
The TEG 6s system helps*:
- Allow targeted blood therapy to optimize clinical outcomes, helping to reduce costs
- Reduce unnecessary transfusions
- Reduce surgical exploration for bleeding
- Provide rapid results in time to make decisions
The TEG 6s analyzer can also run our PlateletMapping® assay, making it the only cartridge-based viscoelastic testing system offering both global hemostasis and receptor-specific platelet function assessment.
Please submit your contact information to download the white paper about how TEG testing supports decision making in cardiac surgery.
*See teg.haemonetics.com/en/references for citations.
© 2019, 2021 Haemonetics Corporation. Haemonetics, TEG and PlateletMapping are trademarks or registered trademarks of Haemonetics Corporation in the USA, other countries, or both. 10.2022 USA. COL-COPY-001721-US(AA)